Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal down39.650 -1.000 (-2.460%)
Disclosure of Interest

06/05/2021 09:16

Venus Medtech (02500) to invest in medical device company

[ET Net News Agency, 6 May 2021] Venus Medtech (Hangzhou) Inc. (02500) said the group
has resolved to invest in Valgen Holding Corporation, an innovative medical device company
registered in the Cayman Islands.
The move is expected to improve Venus's strategic layout in the field of structural
heart disease treatment and grasp development opportunities brought about by the
transcatheter interventional therapy technologies.
ValgenMed is committed to providing systematic solutions for diseases such as mitral
regurgitation and tricuspid regurgitation. ValgenMed has developed MitralStitch, the first
device in China for transcardial interventional treatment of mitral regurgitation,
DragonFly-M, China's first femoral vein mitral valve repair device and DragonFly-T,
China's first femoral vein tricuspid valve repair device, of which MitralStitch and
DragonFly-M have entered pre-marketing registration clinical study stage and DragonFly-T
has entered exploratory clinical study stage. (KL)

Remark: Real time quote last updated: 22/10/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.